ISCTM
ISCTM is dedicated to advancing clinical trial methodology and research in CNS disorders. It aims to improve the design, conduct, and analysis of clinical trials to facilitate the development of effective treatments for neurological and psychiatric conditions. The society fosters collaboration among researchers, clinicians, regulators, and industry to address methodological challenges and promote innovation in CNS drug development.
Industries
Nr. of Employees
small (1-50)
ISCTM
Products
Meeting archives and poster libraries
Publicly accessible and member-access meeting archives containing videos, presentations, poster PDFs, and abstracts from past scientific meetings.
Meeting archives and poster libraries
Publicly accessible and member-access meeting archives containing videos, presentations, poster PDFs, and abstracts from past scientific meetings.
Services
Organization and delivery of annual and autumn scientific meetings, conference sessions, and speaker development resources.
Facilitation of multidisciplinary working groups that draft consensus documents, white papers, and methodological guidance on specific trial issues.
Curated publication of working group manuscripts, meeting proceedings, poster PDFs, and archived session materials for public or member access.
Guidance for speakers and chairs on abstracts, presentations, travel planning, and publication follow-up to support dissemination of session outputs.
Organization and delivery of annual and autumn scientific meetings, conference sessions, and speaker development resources.
Facilitation of multidisciplinary working groups that draft consensus documents, white papers, and methodological guidance on specific trial issues.
Curated publication of working group manuscripts, meeting proceedings, poster PDFs, and archived session materials for public or member access.
Guidance for speakers and chairs on abstracts, presentations, travel planning, and publication follow-up to support dissemination of session outputs.
Expertise Areas
- Clinical trial methodology for CNS indications
- Biomarker strategy and validation
- Rater training and assessment quality
- Statistical methodology and estimand implementation
Key Technologies
- Artificial intelligence / machine learning
- Electronic clinical outcome assessment (eCOA)
- Electroencephalography (EEG)
- Neuroimaging biomarkers
News & Updates
Upcoming conference in Amsterdam, October 9-11, 2025, including joint activities with ECNP.
A session discussing the gut-brain axis, microbiota, and clinical interventional studies using probiotics.
A series of podcasts and episodes celebrating 20 years of ISCTM.
Latest manuscripts from ISCTM working groups on various CNS research topics.
A session exploring the use of drugs with abuse potential in psychiatric disorders and the challenges in clinical development.
A session discussing how AI/ML can improve the efficiency and effectiveness of CNS drug development.
Upcoming conference in Amsterdam, October 9-11, 2025, including joint activities with ECNP.
A session discussing the gut-brain axis, microbiota, and clinical interventional studies using probiotics.
A series of podcasts and episodes celebrating 20 years of ISCTM.
Latest manuscripts from ISCTM working groups on various CNS research topics.
A session exploring the use of drugs with abuse potential in psychiatric disorders and the challenges in clinical development.
A session discussing how AI/ML can improve the efficiency and effectiveness of CNS drug development.